|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium (J.B., K.V.L., S.H., M.F., E.D.C., D.S.); University Hospitals Leuven, Leuven, Belgium (K.V.L.); Department of Clinical Virology, University of Göteborg, Göteborg, Sweden (A.B.); and Department of Molecular Biotechnology, Ghent University, Ghent, Belgium (E.V.D., W.P.)
Abstract
The plant lectins from Hippeastrum hybrid (HHA) and Galanthus nivalis (GNA) are 50,000-D tetramers showing specificity for
-(1,3) and/or
-(1,6)-mannose oligomers. They inhibit HIV-1 infection at a 50% effective concentration of 0.2 to 0.3 µg/ml. Escalating HHA or GNA concentrations (up to 500 µg/ml) led to the isolation of three HIV-1(IIIB) strains in CEM T cell cultures that were highly resistant to HHA and GNA, several other related mannose-specific plant lectins, and the monoclonal antibody 2G12, modestly resistant to the mannose-specific cyanovirin, which is derived from a blue-green alga, but fully susceptible to other HIV entry inhibitors as well as HIV reverse transcriptase inhibitors. These mutant virus strains were devoid of up to seven or eight of 22 glycosylation sites in the viral envelope glycoprotein gp120 because of mutations at the Asn or Thr/Ser sites of the N-glycosylation motifs. In one of the strains, a novel glycosylation site was created near a deleted glycosylation site. The affected glycosylation sites were predominantly clustered in regions of gp120 that are not involved in the direct interaction with either CD4, CCR5, CXCR4, or gp41. The mutant viruses containing the deleted glycosylation sites were markedly more infectious in CEM T-cell cultures than wild-type virus.
Address correspondence to: Prof. J. Balzarini, Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium. E-mail: jan.balzarini{at}rega.kuleuven.ac.be
This article has been cited by other articles:
![]() |
J. G. Joyce, I. J. Krauss, H. C. Song, D. W. Opalka, K. M. Grimm, D. D. Nahas, M. T. Esser, R. Hrin, M. Feng, V. Y. Dudkin, et al. An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions PNAS, October 14, 2008; 105(41): 15684 - 15689. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. U. M. van der Meer, C. A. M. de Haan, N. M. P. Schuurman, B. J. Haijema, M. H. Verheije, B. J. Bosch, J. Balzarini, and H. F. Egberink The carbohydrate-binding plant lectins and the non-peptidic antibiotic pradimicin A target the glycans of the coronavirus envelope glycoproteins J. Antimicrob. Chemother., October 1, 2007; 60(4): 741 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hori, Y. Sato, K. Ito, Y. Fujiwara, Y. Iwamoto, H. Makino, and A. Kawakubo Strict specificity for high-mannose type N-glycans and primary structure of a red alga Eucheuma serra lectin Glycobiology, May 1, 2007; 17(5): 479 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Teuton and C. R. Brandt Sialic Acid on Herpes Simplex Virus Type 1 Envelope Glycoproteins Is Required for Efficient Infection of Cells J. Virol., April 15, 2007; 81(8): 3731 - 3739. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Pashov, J. Plaxco, S. V. Kaveri, B. Monzavi-Karbassi, D. Harn, and T. Kieber-Emmons Multiple Antigenic Mimotopes of HIV Carbohydrate Antigens: Relating Structure and Antigenicity J. Biol. Chem., October 6, 2006; 281(40): 29675 - 29683. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Balzarini, K. Van Laethem, W. J. Peumans, E. J. M. Van Damme, A. Bolmstedt, F. Gago, and D. Schols Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes. J. Virol., September 1, 2006; 80(17): 8411 - 8421. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.M. Blay, S. Gnanakaran, B. Foley, N. A. Doria-Rose, B. T. Korber, and N. L. Haigwood Consistent Patterns of Change during the Divergence of Human Immunodeficiency Virus Type 1 Envelope from That of the Inoculated Virus in Simian/Human Immunodeficiency Virus-Infected Macaques J. Virol., January 15, 2006; 80(2): 999 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Balzarini, K. Van Laethem, S. Hatse, M. Froeyen, W. Peumans, E. Van Damme, and D. Schols Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120: A NEW THERAPEUTIC CONCEPT TO HIT THE ACHILLES HEEL OF HIV J. Biol. Chem., December 9, 2005; 280(49): 41005 - 41014. [Abstract] [Full Text] [PDF] |
||||